Clinical & Pharma

Will Trump's Funding Freeze Disrupt Healthcare and Medicaid Programs?
Clinical & Pharma Will Trump's Funding Freeze Disrupt Healthcare and Medicaid Programs?

The Trump administration's recent decision to suspend a wide range of federal funding has sparked significant confusion and concern within the healthcare industry. This comprehensive freeze, mandated by a directive from Trump’s acting budget director, requires an immediate halt of all financial

Revolutionary Healthcare Innovations: Precision Medicine and CRISPR-Cas9
Clinical & Pharma Revolutionary Healthcare Innovations: Precision Medicine and CRISPR-Cas9

The landscape of healthcare is undergoing a transformative shift, driven by groundbreaking advancements in medical research and technology. Among these innovations, precision medicine and CRISPR-Cas9 genome editing stand out as revolutionary forces poised to redefine patient care and treatment

Will Montana Extend, Modify, or End Medicaid Expansion in 2025?
Clinical & Pharma Will Montana Extend, Modify, or End Medicaid Expansion in 2025?

As the 2025 Montana Legislature approaches, all eyes will be on the significant health care debate centered around the Medicaid expansion program, which impacts over 75,000 low-income residents of Montana and carries an annual cost exceeding $1 billion, jointly funded by federal and state

Is the New WBB Shift System in Malaysian Hospitals Feasible?
Clinical & Pharma Is the New WBB Shift System in Malaysian Hospitals Feasible?

The Waktu Bekerja Berlainan (WBB) shift system has sparked significant debate within Malaysia's healthcare sector. Proposed for government hospitals, this new work schedule aims to restructure how medical professionals operate. However, it has faced substantial opposition from the medical

Can Digital Twins and AI Revolutionize Clinical Trials?
Clinical & Pharma Can Digital Twins and AI Revolutionize Clinical Trials?

Clinical trials have long been the cornerstone of medical advancements, traditionally involving a lengthy and expensive process that can span up to 15 years and cost millions of dollars per trial. This conventional approach often burdens patients with the need to travel to trial sites and

Vietnam's Efforts to Eliminate Hepatitis Evaluated by WHO Experts
Clinical & Pharma Vietnam's Efforts to Eliminate Hepatitis Evaluated by WHO Experts

The recent World Health Organization (WHO) mission to Vietnam focused on evaluating the country's efforts to eliminate viral hepatitis, with a delegation of representatives from WHO, international partners, and experts from the Doherty Institute’s WHO Collaborating Centre for Viral Hepatitis. The

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later